Acquisition by Singer Nicholas Jason of 165800 shares of Eterna Therapeutics subject to Rule 16b-3
ERNA Stock | USD 0.29 0.03 9.38% |
About 58% of all Eterna Therapeutics' investors are looking to take a long position. The analysis of the overall investor sentiment regarding Eterna Therapeutics suggests that some traders are interested. The current market sentiment, together with Eterna Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Eterna Therapeutics stock news signals to limit their universe of possible portfolio assets.
Eterna |
Filed transaction by Eterna Therapeutics Director . Grant, award or other acquisition pursuant to Rule 16b-3
Read at macroaxis.com
Cash Flow Correlation
Eterna Therapeutics' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Eterna Therapeutics' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Eterna Therapeutics Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Eterna Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Eterna Therapeutics Fundamental Analysis
We analyze Eterna Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Eterna Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Eterna Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Eterna Therapeutics is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Eterna Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Eterna Therapeutics stock to make a market-neutral strategy. Peer analysis of Eterna Therapeutics could also be used in its relative valuation, which is a method of valuing Eterna Therapeutics by comparing valuation metrics with similar companies.
Peers
Eterna Therapeutics Related Equities
XFOR | X4 Pharmaceuticals | 11.67 | ||||
PHIO | Phio Pharmaceuticals | 6.30 | ||||
ZURA | Zura Bio | 3.64 | ||||
RNAZ | Transcode Therapeutics | 2.91 | ||||
INZY | Inozyme Pharma | 1.68 | ||||
APLS | Apellis Pharmaceuticals | 1.37 | ||||
DAWN | Day One | 0.47 | ||||
GPCR | Structure Therapeutics | 1.45 | ||||
RLAY | Relay Therapeutics | 1.46 | ||||
ANNX | Annexon | 1.55 | ||||
ABOS | Acumen Pharmaceuticals | 1.93 | ||||
ZVSA | ZyVersa Therapeutics | 2.78 | ||||
ITOS | Iteos Therapeutics | 3.40 | ||||
CGEM | Cullinan Oncology | 3.69 | ||||
UNCY | Unicycive Therapeutics | 4.05 | ||||
IMMX | Immix Biopharma | 4.23 | ||||
TCRX | Tscan Therapeutics | 5.63 | ||||
RCUS | Arcus Biosciences | 6.29 | ||||
REVB | Revelation Biosciences | 12.20 | ||||
PALI | Palisade Bio | 25.00 |
Complementary Tools for Eterna Stock analysis
When running Eterna Therapeutics' price analysis, check to measure Eterna Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eterna Therapeutics is operating at the current time. Most of Eterna Therapeutics' value examination focuses on studying past and present price action to predict the probability of Eterna Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eterna Therapeutics' price. Additionally, you may evaluate how the addition of Eterna Therapeutics to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |